Zaibak said other drugs in this class, called GLP1 receptor agonists, are FDA-approved to be prescribed for weight loss for people with high enough BMIs but not Ozempic
Adults might have their body composition (muscle vs fat mass), bone density, or quality-of-life indicators monitored over longer courses of therapy
The most prescribed GLP-1 drugs include Ozempic, Wegovy, Mounjaro, CagriSema and Rybelsus
While genetics don't perfectly predict individual side effect severity, they reveal your metabolic predispositions across 14 pathways and 49 peptides, enabling truly personalized therapy decisions
Research on GLP-1 medications such as Zepbound and Wegovy shows that reporting outcomes as percentages or average ranges can help standardize results across individuals